Journal article
Targeted radionuclide therapy in combined-modality regimens
Abstract
Targeted radionuclide therapy (TRT) is a branch of cancer medicine concerned with the use of radioisotopes, radiolabelled molecules, nanoparticles, or microparticles that either naturally accumulate in or are designed to target tumours. TRT combines the specificity of molecular and sometimes physical targeting with the potent cytotoxicity of ionising radiation. Targeting vectors for TRT include antibodies, antibody fragments, proteins, …
Authors
Gill MR; Falzone N; Du Y; Vallis KA
Journal
The Lancet Oncology, Vol. 18, No. 7, pp. e414–e423
Publisher
Elsevier
Publication Date
July 2017
DOI
10.1016/s1470-2045(17)30379-0
ISSN
1470-2045